MedTrace Logo

Naltrexone Effects on Alcohol Intake

NCT00254670 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-05-08

No results posted yet for this study

Summary

The purpose of this study is to examine drinking behavior and decision-making while taking Naltrexone and placebo. This is a double-blind, randomized, placebo-controlled crossover study. There are two cycles: one cycle on Naltrexone and one cycle on placebo.

Conditions

  • Social Drinker

Interventions

DRUG

Naltrexone

Sponsors & Collaborators

Principal Investigators

  • Michael C Rowbotham, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2005-12-31
Completion
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00254670 on ClinicalTrials.gov